Bausch Health Companies Inc BHC
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover BHC, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Bausch Health responds to rumors, says it is not considering bankruptcy
-
Bausch Health Responds to Market Rumors
-
Bausch Health Welcomes Two New Members to the Executive Leadership Team
-
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
-
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
-
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
-
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
-
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
Trading Information
- Previous Close Price
- $5.88
- Day Range
- $5.69–6.04
- 52-Week Range
- $3.96–11.46
- Bid/Ask
- $5.40 / $6.00
- Market Cap
- $2.20 Bil
- Volume/Avg
- 5.2 Mil / 3.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 1.68
- Price/Sales
- 0.24
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 20,270
- Website
- https://www.bauschhealth.com
Comparables
Valuation
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Price/Earnings (Normalized) | 1.68 | 21.82 | 4.30 |
Price/Book Value | — | 0.85 | 1.06 |
Price/Sales | 0.24 | 1.32 | 0.87 |
Price/Cash Flow | 1.33 | 21.79 | 4.26 |
Price/Earnings
BHC
BLCO
ASRT
Financial Strength
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Quick Ratio | 0.63 | 0.76 | 1.33 |
Current Ratio | 1.22 | 1.70 | 1.87 |
Interest Coverage | 0.74 | 0.35 | −96.25 |
Quick Ratio
BHC
BLCO
ASRT
Profitability
|
Metric
|
BHC
|
BLCO
|
ASRT
|
|---|---|---|---|
Return on Assets (Normalized) | 4.93% | 1.99% | 8.43% |
Return on Equity (Normalized) | — | 3.62% | 15.37% |
Return on Invested Capital (Normalized) | 9.78% | 4.10% | 13.68% |
Return on Assets
BHC
BLCO
ASRT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jjgvyrryp | Mdrnb | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Lxgnkcdmfv | Xhxrb | $73.2 Bil | |||
| Haleon PLC ADR
HLN
| Khlhfjty | Sbx | $41.0 Bil | |||
| Viatris Inc
VTRS
| Gfpqqqfd | Fcvbh | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pgwhhbsp | Xpcq | $13.7 Bil | |||
| Catalent Inc
CTLT
| Qxyyfssf | Xvylhpt | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Jshfcdvm | Xkrdl | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gdmgmsxq | Xwrqgq | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Xtwqfcwm | Qvp | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Tpvcwntd | Zbwby | $2.7 Bil |